These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 26971641)

  • 1. Evaluation of matrix-assisted laser desorption ionization-time-of-flight mass spectrometry to differentiate between Candida albicans and Candida dubliniensis.
    Roberts AL; Alelew A; Iwen PC
    Diagn Microbiol Infect Dis; 2016 May; 85(1):73-6. PubMed ID: 26971641
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differentiation of Candida dubliniensis from Candida albicans by means of MALDI-TOF mass spectrometry.
    Hof H; Eigner U; Maier T; Staib P
    Clin Lab; 2012; 58(9-10):927-31. PubMed ID: 23163108
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Matrix-assisted laser desorption/ionization time-of-flight intact cell mass spectrometry to detect emerging pathogenic Candida species.
    Santos C; Lima N; Sampaio P; Pais C
    Diagn Microbiol Infect Dis; 2011 Nov; 71(3):304-8. PubMed ID: 21855250
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of two matrix-assisted laser desorption ionization-time of flight mass spectrometry (MALDI-TOF MS) systems for the identification of Candida species.
    Lacroix C; Gicquel A; Sendid B; Meyer J; Accoceberry I; François N; Morio F; Desoubeaux G; Chandenier J; Kauffmann-Lacroix C; Hennequin C; Guitard J; Nassif X; Bougnoux ME
    Clin Microbiol Infect; 2014 Feb; 20(2):153-8. PubMed ID: 23594150
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterising atypical Candida albicans clinical isolates from six third-level hospitals in Bogotá, Colombia.
    Rodríguez-Leguizamón G; Fiori A; López LF; Gómez BL; Parra-Giraldo CM; Gómez-López A; Suárez CF; Ceballos A; Van Dijck P; Patarroyo MA
    BMC Microbiol; 2015 Oct; 15():199. PubMed ID: 26438104
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [A comparison of the costs, reliability and time of result periods of widely used methods, new molecular methods and MALDI TOF-MS in the routine diagnosis of Candida strains].
    Kal Çakmaklıoğulları E; Aşgın N; Değerli K
    Mikrobiyol Bul; 2019 Apr; 53(2):204-212. PubMed ID: 31130124
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Investigation of minor species Candida africana, Candida stellatoidea and Candida dubliniensis in the Candida albicans complex among Yaoundé (Cameroon) HIV-infected patients.
    Ngouana TK; Krasteva D; Drakulovski P; Toghueo RK; Kouanfack C; Ambe A; Reynes J; Delaporte E; Boyom FF; Mallié M; Bertout S
    Mycoses; 2015 Jan; 58(1):33-9. PubMed ID: 25289589
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of triazole resistance among Candida species by matrix-assisted laser desorption/ionization-time of flight mass spectrometry (MALDI-TOF MS).
    Saracli MA; Fothergill AW; Sutton DA; Wiederhold NP
    Med Mycol; 2015 Sep; 53(7):736-42. PubMed ID: 26162474
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of cryptic Candida species by MALDI-TOF mass spectrometry, not all MALDI-TOF systems are the same: focus on the C. parapsilosis species complex.
    Haas M; Grenouillet F; Loubersac S; Ariza B; Pepin-Puget L; Alvarez-Moreno CA; Valderrama-Beltrán SL; Lavergne RA; Le Pape P; Morio F
    Diagn Microbiol Infect Dis; 2016 Dec; 86(4):385-386. PubMed ID: 27682360
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Matrix-assisted laser desorption/ionization time of flight mass spectrometry (MALDI-TOF MS) and Bayesian phylogenetic analysis to characterize Candida clinical isolates.
    Angeletti S; Lo Presti A; Cella E; Dicuonzo G; Crea F; Palazzotti B; Dedej E; Ciccozzi M; De Florio L
    J Microbiol Methods; 2015 Dec; 119():214-22. PubMed ID: 26551247
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Matrix-assisted laser desorption ionization time-of-flight (MALDI-TOF) mass spectrometry vs conventional methods in the identification of Candida non-albicans].
    Martínez-Lamas L; Pérez del Molino ML; Pardo F; Varela E; Regueiro BJ
    Enferm Infecc Microbiol Clin; 2011 Oct; 29(8):568-72. PubMed ID: 21782293
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of MALDI-TOF mass spectra with microsatellite length polymorphisms in Candida albicans.
    Dhieb C; Normand AC; L'Ollivier C; Gautier M; Vranckx K; El Euch D; Chaker E; Hendrickx M; Dalle F; Sadfi N; Piarroux R; Ranque S
    J Mass Spectrom; 2015 Feb; 50(2):371-7. PubMed ID: 25800019
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification and typing of the emerging pathogen Candida auris by matrix-assisted laser desorption ionisation time of flight mass spectrometry.
    Girard V; Mailler S; Chetry M; Vidal C; Durand G; van Belkum A; Colombo AL; Hagen F; Meis JF; Chowdhary A
    Mycoses; 2016 Aug; 59(8):535-8. PubMed ID: 27292939
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Performance of matrix-assisted laser desorption-time of flight mass spectrometry for identification of clinical yeast isolates.
    Rosenvinge FS; Dzajic E; Knudsen E; Malig S; Andersen LB; Løvig A; Arendrup MC; Jensen TG; Gahrn-Hansen B; Kemp M
    Mycoses; 2013 May; 56(3):229-35. PubMed ID: 22924975
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence of genotypic diversity among Candida auris isolates by multilocus sequence typing, matrix-assisted laser desorption ionization time-of-flight mass spectrometry and amplified fragment length polymorphism.
    Prakash A; Sharma C; Singh A; Kumar Singh P; Kumar A; Hagen F; Govender NP; Colombo AL; Meis JF; Chowdhary A
    Clin Microbiol Infect; 2016 Mar; 22(3):277.e1-9. PubMed ID: 26548511
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of the MALDI TOF-MS method for identification of Candida strains isolated from blood cultures.
    Yaman G; Akyar I; Can S
    Diagn Microbiol Infect Dis; 2012 May; 73(1):65-7. PubMed ID: 22578939
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rapid and reliable MALDI-TOF mass spectrometry identification of Candida non-albicans isolates from bloodstream infections.
    Pulcrano G; Iula DV; Vollaro A; Tucci A; Cerullo M; Esposito M; Rossano F; Catania MR
    J Microbiol Methods; 2013 Sep; 94(3):262-6. PubMed ID: 23845229
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Diagnostic accuracy of MALDI-TOF mass spectrum in identification of oral Candidiasis isolates].
    Wei P; Fu JY; Zahng YF; Lyu X; Guan XB; Yan ZM; Chen F; Hua H
    Shanghai Kou Qiang Yi Xue; 2020 Dec; 29(6):567-572. PubMed ID: 33778820
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High prevalence of Candida dubliniensis in lower respiratory tract secretions from cystic fibrosis patients may be related to increased adherence properties.
    Wahab AA; Taj-Aldeen SJ; Kolecka A; ElGindi M; Finkel JS; Boekhout T
    Int J Infect Dis; 2014 Jul; 24():14-9. PubMed ID: 24780917
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Matrix-assisted laser desorption ionization time-of-flight mass spectrometry for the rapid identification of yeasts causing bloodstream infections.
    Ghosh AK; Paul S; Sood P; Rudramurthy SM; Rajbanshi A; Jillwin TJ; Chakrabarti A
    Clin Microbiol Infect; 2015 Apr; 21(4):372-8. PubMed ID: 25658527
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.